Latest

• Cefodizime: pharmacological characteristics and potential for clinical use in lower respiratory tract infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):277-282

• Doxycycline in the current clinical practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):21-28

• To stop the progress of antimicrobial resistance today means to give a chance of mankind surviving tomorrow

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):310-315

• Oral third-generation cephalosporins in the treatment of community-acquired urinary tract infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):225-228

• Cefotaxime/sulbactam: clinical and pharmacological characteristics

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):212-216

• Ceftolozane/tazobactam – the «new player» in a battle against multiresistant pathogens

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):354-361

• Penicillin/Beta-lactamase Inhibitor Combinations in the Treatment of Bacterial Respiratory Tract Infections in Children

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(3):191-195

• Potential of the Introduction of Tedizolid for the Treatment of Complicated Skin and Soft Tissue Infections in a Russian Multi-Field Hospital

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(3):174-185

• Antimicrobial Resistance of Gram-negative Microorganisms Causing Complicated Intra-abdominal Infections in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(3):227-234

• Oral Third-Generation Cephalosporins in Current Outpatient Clinical Practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(1):18-23

• Choice of Antimicrobial Agents in Uncomplicated Urinary Tract Infections: How to Make Decision Worthy of Solomon?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(1):18-25

• Ceftaroline – «Sui Generis»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):124-130

• «Respiratory» Fluoroquinolones – the Neoclassics of Antimicrobial Chemotherapy

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(1):47-55

• Bacterial Biofilms – a New Therapeutic Target?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(1):23-29

• Antimicrobial Stewardship as a Renascence of the ‘Golden Age’ of Antibiotics

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(4):322-334

• Antimicrobial Therapy of Complicated Intra-abdominal Infections: What are the Success Determinants?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(2):158-162

• New Opportunities for Prevention of Surgical Site Infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(1):56-66

• Tobramycin in Current Clinical Practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):321-328

• Ciprofloxacin in Current Clinical Practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):154-162

• Catheter-related Bloodstream Infections: Prevention or Treatment?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):23-30

• Specifics of Russian Pharmaceutical Market in the XXI Century: Original Drugs or Generics?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(4):335-340

• Antimicrobial Prophylaxis in Colorectal Surgery

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(3):244-252